Abstract
Introduction: Obesity is a serious, worldwide and growing problem, with associated complications ranging from cardiovascular disease to cancer. It has been suggested that a subgroup of obese patients- the “metabolically healthy” (MH)- would constitute a phenotype whose cardiovascular risk would be closer to that of normal weight individuals and lower than that of obese patients with other risk factors. The definitions of MH obesity are heterogeneous, what makes the estimation of its prevalence quite difficult. Besides that, data are still controversial about the risk of incident cardiovascular disease in these patients and therefore this remains an unresolved matter. In parallel, the possibly lower risk of MH obesity may raise questions about the need for weight loss in MH obese patients.
Conclusion: This issue should be carefully addressed, and evidence for a “benign” profile of MH obesity critically evaluated, as obesity is a risk factor for numerous health outcomes, and weight loss in obese people additionally offers protection against these nonmetabolic diseases.
Keywords: Obesity, metabolic syndrome, cardiovascular disease, prognosis, diabetes, healthy.
Current Diabetes Reviews
Title:“Metabolically Healthy” Obesity: Fact or Threat?
Volume: 14 Issue: 5
Author(s): Andrea De Lorenzo*, Cristiane da Cruz Lamas, Rafael Lessa and Annie Seixas Bello Moreira
Affiliation:
- Instituto Nacional de Cardiologia, Rua das Laranjeiras 374, Rio de Janeiro, RJ,Brazil
Keywords: Obesity, metabolic syndrome, cardiovascular disease, prognosis, diabetes, healthy.
Abstract: Introduction: Obesity is a serious, worldwide and growing problem, with associated complications ranging from cardiovascular disease to cancer. It has been suggested that a subgroup of obese patients- the “metabolically healthy” (MH)- would constitute a phenotype whose cardiovascular risk would be closer to that of normal weight individuals and lower than that of obese patients with other risk factors. The definitions of MH obesity are heterogeneous, what makes the estimation of its prevalence quite difficult. Besides that, data are still controversial about the risk of incident cardiovascular disease in these patients and therefore this remains an unresolved matter. In parallel, the possibly lower risk of MH obesity may raise questions about the need for weight loss in MH obese patients.
Conclusion: This issue should be carefully addressed, and evidence for a “benign” profile of MH obesity critically evaluated, as obesity is a risk factor for numerous health outcomes, and weight loss in obese people additionally offers protection against these nonmetabolic diseases.
Export Options
About this article
Cite this article as:
De Lorenzo Andrea*, da Cruz Lamas Cristiane, Lessa Rafael and Moreira Seixas Bello Annie , “Metabolically Healthy” Obesity: Fact or Threat?, Current Diabetes Reviews 2018; 14 (5) . https://dx.doi.org/10.2174/1573399813666170502105859
DOI https://dx.doi.org/10.2174/1573399813666170502105859 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
ATP-Containing Immunoliposomes Specific for Cardiac Myosin
Current Drug Delivery Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
Current Drug Targets The Role of the Chemokines in Myocardial Ischemia and Reperfusion
Current Vascular Pharmacology 5-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets The Enigmatic Drug Binding Site for Sodium Channel Inhibitors
Current Molecular Pharmacology Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine Water and Ion Channels: Crucial in the Initiation and Progression of Apoptosis in Central Nervous System?
Current Neuropharmacology Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine Unusual Clinical Manifestations of the Antiphospholipid Syndrome
Current Rheumatology Reviews Apoptotic and Anti-Angiogenic Effects of Benzimidazole Compounds: Relationship with Oxidative Stress Mediated Ischemia/Reperfusion Injury in Rat Hind Limb
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Current Vascular Pharmacology Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Molecular Links Between Endothelial Dysfunction and Neurodegeneration in Alzheimer's Disease
Current Alzheimer Research Influenza and Stroke Risk: A Key Target Not to be Missed?
Infectious Disorders - Drug Targets Development and Clinical use of Prasugrel and Ticagrelor
Current Pharmaceutical Design Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Current Neuropharmacology Role of Chymase in Preeclampsia
Current Vascular Pharmacology Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued) The Evidence Base for Revascularisation of Chronic Total Occlusions
Current Cardiology Reviews Modulation of Cardiac and Hepatic Cytochrome P450 Enzymes During Heart Failure
Current Drug Metabolism